Avascular Necrosis Epidemiology Forecast 2024-2032

Avascular Necrosis Epidemiology Forecast Report Coverage

Expert Market Research's “Avascular Necrosis Epidemiology Forecast Report 2024-2032” offers comprehensive information on the prevalence and demographics of avascular necrosis. It projects the future incidence and prevalence rates of avascular necrosis across various populations. The study covers age and type as major determinants of the avascular necrosis-affected population. The report highlights patterns in the prevalence of avascular necrosis over time and projects future trends based on multiple variables.

Avascular Necrosis: Disease Overview

Avascular necrosis, also known as osteonecrosis or bone infarction, is characterized by the death of bone tissue. It occurs due to the permanent or temporary loss of blood supply to the bone. Although avascular necrosis can affect any bone, it primarily occurs in the ends of long bone. Common symptoms include limited range of motion, intermittent pain, increasing pain and stiff joints, and limping, among others.

Avascular Necrosis: Treatment Overview

The treatment plan for avascular necrosis depends on the severity and location of the disease along with the patient’s profile (age and general health). Anti-inflammatory drugs (NSAIDs) are commonly used for pain relief. Limited weight bearing with crutches or immobilization may help in certain cases. However, in advanced avascular necrosis cases, the patient often needs surgery as the disease course is unaffected by activity.

Epidemiology

The avascular necrosis epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for avascular necrosis by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for avascular necrosis and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• In the United States, it is estimated that 15,000 new cases of avascular necrosis occur annually. Moreover, this degenerative bone disease is responsible for 10% of total hip replacement surgeries performed in the country.
• Avascular necrosis usually affects people between the ages of 30 to 65.
• Studies report that men tend to be more affected by the condition compared to women, showing an overall male-to-female ratio of 8:1.
• As per Lamb, Jonathan N et al. (2019), in the United Kingdom, avascular necrosis is reported as the third most common cause of total hip replacement in the patient population under 50 years of age.

Country-wise Avascular Necrosis Epidemiology

The avascular necrosis epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of avascular necrosis varies significantly between countries owing to the differences in the prevalence of risk factors (such as alcohol abuse, corticosteroid use, and metabolic disorders), genetic predisposition, and access to healthcare, among others. In many Asian countries, like India, avascular necrosis is highly prevalent and ranks as one of the leading indications for total hip arthroplasty (THA). According to a study published in the Journal of Orthopaedics (2022), avascular necrosis is the most common indication for total hip arthroplasty in India (approximately 52%).

Country Specific Stats:

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of avascular necrosis based on several factors.
• Avascular Necrosis Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of avascular necrosis are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of avascular necrosis epidemiology in the 8 major markets?
• What will be the total number of patients with avascular necrosis across the 8 major markets during the forecast period?
• What was the country-wise prevalence of avascular necrosis in the 8 major markets in the historical period?
• Which country will have the highest number of avascular necrosis patients during the forecast period of 2024-2032?
• Which key factors would influence the shift in the patient population of avascular necrosis during the forecast period of 2024-2032?
• What are the currently available treatments for avascular necrosis?
• What are the disease risks, signs, symptoms, and unmet needs of avascular necrosis?

Related Reports

Global Hip Replacement Implants Market

Global CAR T-Cell Therapy Market